| Dr John Bradford Ingram, MD | |
|
2500 N State St, Jackson, MS 39216-4500 | |
| (601) 984-5211 | |
| Not Available |
| Full Name | Dr John Bradford Ingram |
|---|---|
| Gender | Male |
| Speciality | Neurology |
| Experience | 19 Years |
| Location | 2500 N State St, Jackson, Mississippi |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1134319619 | NPI | - | NPPES |
| 08888868 | Medicaid | MS |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| State Of Mississippi - University Of Mississippi Medical Center | 1850293036 | 804 |
News Archive
A study carried out by researchers at Massachusetts General Hospital (MGH) and the Perelman School of Medicine at the University of Pennsylvania finds that low wages and poor benefits leave many female health care workers living below the poverty line.
A global report published by the WHO, titled "Mortality Attributable to Tobacco," "provides information by country on the proportion of adult (age 30 years and above) deaths attributable to tobacco by major communicable and non-communicable causes by age and sex," the agency's website states.
Taro Pharmaceutical Industries Ltd. reported today that it has received approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Application (ANDA) for Imiquimod Cream, 5%.
Gen-Probe Incorporated announced today that its board of directors has authorized the repurchase of up to $150 million of the Company's common stock over the next year.
Sinobiopharma, Inc. ("Sinobiopharma") (the "Company") is pleased to announce that the Company received a certificate for the use of Gabexate mesylate as a pharmaceutical raw material (Certificate #2009S01805) from the Chinese State Food and Drug Administration ("SFDA").
› Verified 7 days ago
| Entity Name | Rush Medical Foundation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1588625594 PECOS PAC ID: 2567368541 Enrollment ID: O20031210000541 |
News Archive
A study carried out by researchers at Massachusetts General Hospital (MGH) and the Perelman School of Medicine at the University of Pennsylvania finds that low wages and poor benefits leave many female health care workers living below the poverty line.
A global report published by the WHO, titled "Mortality Attributable to Tobacco," "provides information by country on the proportion of adult (age 30 years and above) deaths attributable to tobacco by major communicable and non-communicable causes by age and sex," the agency's website states.
Taro Pharmaceutical Industries Ltd. reported today that it has received approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Application (ANDA) for Imiquimod Cream, 5%.
Gen-Probe Incorporated announced today that its board of directors has authorized the repurchase of up to $150 million of the Company's common stock over the next year.
Sinobiopharma, Inc. ("Sinobiopharma") (the "Company") is pleased to announce that the Company received a certificate for the use of Gabexate mesylate as a pharmaceutical raw material (Certificate #2009S01805) from the Chinese State Food and Drug Administration ("SFDA").
› Verified 7 days ago
| Entity Name | Laird Hospital, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1821046798 PECOS PAC ID: 7214991769 Enrollment ID: O20050201000304 |
News Archive
A study carried out by researchers at Massachusetts General Hospital (MGH) and the Perelman School of Medicine at the University of Pennsylvania finds that low wages and poor benefits leave many female health care workers living below the poverty line.
A global report published by the WHO, titled "Mortality Attributable to Tobacco," "provides information by country on the proportion of adult (age 30 years and above) deaths attributable to tobacco by major communicable and non-communicable causes by age and sex," the agency's website states.
Taro Pharmaceutical Industries Ltd. reported today that it has received approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Application (ANDA) for Imiquimod Cream, 5%.
Gen-Probe Incorporated announced today that its board of directors has authorized the repurchase of up to $150 million of the Company's common stock over the next year.
Sinobiopharma, Inc. ("Sinobiopharma") (the "Company") is pleased to announce that the Company received a certificate for the use of Gabexate mesylate as a pharmaceutical raw material (Certificate #2009S01805) from the Chinese State Food and Drug Administration ("SFDA").
› Verified 7 days ago
| Entity Name | Scott Regional Medical Center, Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1639367188 PECOS PAC ID: 0648366260 Enrollment ID: O20080423000448 |
News Archive
A study carried out by researchers at Massachusetts General Hospital (MGH) and the Perelman School of Medicine at the University of Pennsylvania finds that low wages and poor benefits leave many female health care workers living below the poverty line.
A global report published by the WHO, titled "Mortality Attributable to Tobacco," "provides information by country on the proportion of adult (age 30 years and above) deaths attributable to tobacco by major communicable and non-communicable causes by age and sex," the agency's website states.
Taro Pharmaceutical Industries Ltd. reported today that it has received approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Application (ANDA) for Imiquimod Cream, 5%.
Gen-Probe Incorporated announced today that its board of directors has authorized the repurchase of up to $150 million of the Company's common stock over the next year.
Sinobiopharma, Inc. ("Sinobiopharma") (the "Company") is pleased to announce that the Company received a certificate for the use of Gabexate mesylate as a pharmaceutical raw material (Certificate #2009S01805) from the Chinese State Food and Drug Administration ("SFDA").
› Verified 7 days ago
| Entity Name | State Of Mississippi - University Of Mississippi Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1154317527 PECOS PAC ID: 1850293036 Enrollment ID: O20090414000575 |
News Archive
A study carried out by researchers at Massachusetts General Hospital (MGH) and the Perelman School of Medicine at the University of Pennsylvania finds that low wages and poor benefits leave many female health care workers living below the poverty line.
A global report published by the WHO, titled "Mortality Attributable to Tobacco," "provides information by country on the proportion of adult (age 30 years and above) deaths attributable to tobacco by major communicable and non-communicable causes by age and sex," the agency's website states.
Taro Pharmaceutical Industries Ltd. reported today that it has received approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Application (ANDA) for Imiquimod Cream, 5%.
Gen-Probe Incorporated announced today that its board of directors has authorized the repurchase of up to $150 million of the Company's common stock over the next year.
Sinobiopharma, Inc. ("Sinobiopharma") (the "Company") is pleased to announce that the Company received a certificate for the use of Gabexate mesylate as a pharmaceutical raw material (Certificate #2009S01805) from the Chinese State Food and Drug Administration ("SFDA").
› Verified 7 days ago
| Entity Name | Kemper Cah, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1346546306 PECOS PAC ID: 5991985012 Enrollment ID: O20110622000294 |
News Archive
A study carried out by researchers at Massachusetts General Hospital (MGH) and the Perelman School of Medicine at the University of Pennsylvania finds that low wages and poor benefits leave many female health care workers living below the poverty line.
A global report published by the WHO, titled "Mortality Attributable to Tobacco," "provides information by country on the proportion of adult (age 30 years and above) deaths attributable to tobacco by major communicable and non-communicable causes by age and sex," the agency's website states.
Taro Pharmaceutical Industries Ltd. reported today that it has received approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Application (ANDA) for Imiquimod Cream, 5%.
Gen-Probe Incorporated announced today that its board of directors has authorized the repurchase of up to $150 million of the Company's common stock over the next year.
Sinobiopharma, Inc. ("Sinobiopharma") (the "Company") is pleased to announce that the Company received a certificate for the use of Gabexate mesylate as a pharmaceutical raw material (Certificate #2009S01805) from the Chinese State Food and Drug Administration ("SFDA").
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr John Bradford Ingram, MD 2500 N State St, Jackson, MS 39216-4500 Ph: (601) 984-5211 | Dr John Bradford Ingram, MD 2500 N State St, Jackson, MS 39216-4500 Ph: (601) 984-5211 |
News Archive
A study carried out by researchers at Massachusetts General Hospital (MGH) and the Perelman School of Medicine at the University of Pennsylvania finds that low wages and poor benefits leave many female health care workers living below the poverty line.
A global report published by the WHO, titled "Mortality Attributable to Tobacco," "provides information by country on the proportion of adult (age 30 years and above) deaths attributable to tobacco by major communicable and non-communicable causes by age and sex," the agency's website states.
Taro Pharmaceutical Industries Ltd. reported today that it has received approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Application (ANDA) for Imiquimod Cream, 5%.
Gen-Probe Incorporated announced today that its board of directors has authorized the repurchase of up to $150 million of the Company's common stock over the next year.
Sinobiopharma, Inc. ("Sinobiopharma") (the "Company") is pleased to announce that the Company received a certificate for the use of Gabexate mesylate as a pharmaceutical raw material (Certificate #2009S01805) from the Chinese State Food and Drug Administration ("SFDA").
› Verified 7 days ago
Lamar Davis Ii, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 2500 N State St, Jackson, MS 39216 Phone: 601-984-5275 | |
Dr. Patrick E Weldon, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 1860 Chadwick Drive, Suite 258, Jackson, MS 39204 Phone: 601-376-2004 Fax: 601-376-2006 | |
Derek Letort, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 1200 N State St Ste 420, Jackson, MS 39202 Phone: 601-355-3353 Fax: 601-355-3365 | |
James Thompson, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 2500 N State St, Ummc Department Of Pediatrics, Jackson, MS 39216 Phone: 601-984-5200 Fax: 601-984-2086 | |
Dr. Jahanzeb Khan, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 2500 N State St, Jackson, MS 39216 Phone: 601-984-1000 Fax: 601-815-0434 | |
Dr. Kelsey Hillhouse Carr, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 2500 N State St, Jackson, MS 39216 Phone: 601-984-5514 | |
Dr. Tiffany Hoi-yan Pike-lee, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 2500 N State St, Jackson, MS 39216 Phone: 330-808-8117 |